Literature DB >> 28350513

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Antonia R Sepulveda1, Stanley R Hamilton1, Carmen J Allegra1, Wayne Grody1, Allison M Cushman-Vokoun1, William K Funkhouser1, Scott E Kopetz1, Christopher Lieu1, Noralane M Lindor1, Bruce D Minsky1, Federico A Monzon1, Daniel J Sargent1, Veena M Singh1, Joseph Willis1, Jennifer Clark1, Carol Colasacco1, R Bryan Rumble1, Robyn Temple-Smolkin1, Christina B Ventura1, Jan A Nowak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28350513     DOI： 10.1200/JOP.2017.022152

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  8 in total

1.  Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis.

Authors:  Qiaoxin Zhang; Yong Xia; Yanxuan Xie; Xiaoyang Jiao; Mi Zeng; Zhiqiang Fan; Xin Li; Yumeng Yuan
Journal:  Cancer Manag Res       Date:  2022-10-18       Impact factor: 3.602

2.  Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel.

Authors:  Dario de Biase; Giorgia Acquaviva; Michela Visani; Viviana Sanza; Chiara M Argento; Antonio De Leo; Thais Maloberti; Annalisa Pession; Giovanni Tallini
Journal:  Diagnostics (Basel)       Date:  2020-04-23

Review 3.  Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?

Authors:  Annika Blank; Daniel Edward Roberts; Heather Dawson; Inti Zlobec; Alessandro Lugli
Journal:  Front Med (Lausanne)       Date:  2018-08-31

Review 4.  The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.

Authors:  Giuseppe Nicolò Fanelli; Carlo Alberto Dal Pozzo; Ilaria Depetris; Fotios Loupakis; Matteo Fassan; Marta Schirripa; Stefano Brignola; Paola Biason; Mariangela Balistreri; Luca Dal Santo; Sara Lonardi; Giada Munari
Journal:  Cancer Cell Int       Date:  2020-01-29       Impact factor: 5.722

5.  Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients.

Authors:  Wen-Long Guan; Miao-Zhen Qiu; Cai-Yun He; Li-Qiong Yang; Ying Jin; Zhi-Qiang Wang; Yu-Hong Li; Rui-Hua Xu; Feng-Hua Wang
Journal:  Front Oncol       Date:  2020-11-23       Impact factor: 6.244

6.  Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Authors:  Leah M Prentice; Ruth R Miller; Jeff Knaggs; Alborz Mazloomian; Rosalia Aguirre Hernandez; Patrick Franchini; Kourosh Parsa; Basile Tessier-Cloutier; Anna Lapuk; David Huntsman; David F Schaeffer; Brandon S Sheffield
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

7.  LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.

Authors:  Zhidong Yang; Yue An; Ningning Wang; Xihua Dong; Hui Kang
Journal:  J Cell Physiol       Date:  2020-02-16       Impact factor: 6.384

8.  Metastatic colon cancer of the small intestine diagnosed using genetic analysis: a case report.

Authors:  Mikiko Matsuo; Yuichiro Hatano; Yuko Imaizumi; Takahiro Kuroda; Toshinori Arai; Hiroyuki Tomita; Nobuhisa Matsuhashi; Kazuhiro Yoshida; Akira Hara
Journal:  Diagn Pathol       Date:  2020-08-31       Impact factor: 2.644
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.